References
1. Bassetti M, Garnacho-Montero J, Calandra T, et al. Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive care medicine. 2017;43(9):1225-1238.
2. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020;71(6):1367-1376.
3. Chen K, Zhang X, Ke X, Du G, Yang K, Zhai S. Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.Therapeutic drug monitoring. 2018;40(6):663-674.
4. Cadena J, Thompson GR, 3rd, Patterson TF. Aspergillosis: Epidemiology, Diagnosis, and Treatment. Infectious disease clinics of North America. 2021;35(2):415-434.
5. Veringa A, Ter Avest M, Span LF, et al. Voriconazole metabolism is influenced by severe inflammation: a prospective study. The Journal of antimicrobial chemotherapy. 2017;72(1):261-267.
6. Gautier-Veyret E, Bailly S, Fonrose X, et al. Pharmacogenetics may influence the impact of inflammation on voriconazole trough concentrations. 2017;18(12):1119-1123.
7. Ivanov M, Barragan I, Ingelman-Sundberg M. Epigenetic mechanisms of importance for drug treatment. Trends in Pharmacological Sciences. 2014;35(8):384-396.
8. Fisel P, Schaeffeler E, Schwab M. DNA Methylation of ADME Genes.Clinical pharmacology and therapeutics. 2016;99(5):512-527.
9. Hao X, Li Y, Bian J, et al. Impact of DNA methylation on ADME gene expression, drug disposition, and efficacy. Drug metabolism reviews. 2022;54(2):194-206.
10. Tang X, Ge L, Chen Z, et al. Methylation of the Constitutive Androstane Receptor Is Involved in the Suppression of CYP2C19 in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Drug metabolism and disposition: the biological fate of chemicals.2016;44(10):1643-1652.
11. Burns KE, Shepherd P, Finlay G, Tingle MD, Helsby NA. Indirect regulation of CYP2C19 gene expression via DNA methylation.Xenobiotica; the fate of foreign compounds in biological systems.2018;48(8):781-792.
12. Bian J, Zhao J, Zhao Y, et al. Impact of individual factors on DNA methylation of drug metabolism genes: A systematic review.Environmental and Molecular Mutagenesis. 2023;64(7):401-415.
13. Burns KE, Lo WY, Findlay MP, Sharples K, Laking G, Helsby NA. High CYP2C19 phenotypic variability in gastrointestinal cancer patients.Cancer chemotherapy and pharmacology. 2015;77(1):195-204.
14. Helsby NA, Lo WY, Sharples K, et al. CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype.British Journal of Cancer. 2008;99(8):1251-1255.
15. Burns KE, Goldthorpe MA, Porteus F, Browett P, Helsby NA. CYP2C19 genotype-phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity. Cancer chemotherapy and pharmacology. 2014;73(3):651-655.
16. Clermont V, Grangeon A, Barama A, et al. Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine. British journal of clinical pharmacology. 2019;85(6):1367-1377.
17. Sukmawan R, Hoetama E, Suridanda Danny S, et al. Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI). Pharmacology research & perspectives. 2021;9(2):e00738.
18. van Wanrooy MJ, Span LF, Rodgers MG, et al. Inflammation is associated with voriconazole trough concentrations. Antimicrobial agents and chemotherapy. 2014;58(12):7098-7101.
19. Luo X, Li T, Hu L, et al. Differential effects of C-reactive protein levels on voriconazole metabolism at three age groups in allogeneic hematopoietic cell transplant recipients. Journal of chemotherapy (Florence, Italy). 2021;33(2):95-105.
20. Netea MG, Balkwill F, Chonchol M, et al. A guiding map for inflammation. Nat Immunol. 2017;18(8):826-831.
21. Renton KW. Regulation of drug metabolism and disposition during inflammation and infection. Expert opinion on drug metabolism & toxicology. 2005;1(4):629-640.
22. Deb S, Arrighi S. Potential Effects of COVID-19 on Cytochrome P450-Mediated Drug Metabolism and Disposition in Infected Patients.European journal of drug metabolism and pharmacokinetics.2021;46(2):185-203.
23. Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Annual review of pharmacology and toxicology. 2006;46:123-149.
24. Roffey SJ, Cole S, Comby P, et al. The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug metabolism and disposition: the biological fate of chemicals. 2003;31(6):731-741.
25. Li J, Ma J, Wagar EA, Liang D, Meng QH. A rapid ultra-performance LC-MS/MS assay for determination of serum unbound fraction of voriconazole in cancer patients. Clinica chimica acta; international journal of clinical chemistry. 2018;486:36-41.
26. Chantharit P, Tantasawat M, Kasai H, Tanigawara Y. Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization. Therapeutic drug monitoring.2020;42(6):872-879.
27. Zhong XB, Lai Y. Special Section On Drug Metabolism in Liver Injury and Repair-Editorial. Drug metabolism and disposition: the biological fate of chemicals. 2022;50(5):634-635.
28. Tang D, Yan M, Song BL, et al. Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study. British journal of clinical pharmacology. 2021;87(4):1890-1902.
29. Liang Z, Yu M, Liu Z, et al. Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients. Frontiers in pharmacology. 2022;13:835871.
30. Olsson Lindvall M, Angerfors A, Andersson B, et al. Comparison of DNA Methylation Profiles of Hemostatic Genes between Liver Tissue and Peripheral Blood within Individuals. Thrombosis and haemostasis.2021;121(5):573-583.
31. Xu L, Wang Y. Combined influence of ABCB1 genetic polymorphism and DNA methylation on aspirin resistance in Chinese ischemic stroke patients. Acta neurologica Belgica. 2021.
32. Li X, Zhao K, Ma N, Sun S, Miao Z, Zhao Z. Association of ABCB1 promoter methylation with aspirin exposure, platelet function, and clinical outcomes in Chinese intracranial artery stenosis patients.European journal of clinical pharmacology. 2017;73(10):1261-1269.